Evidence-Based Medicine Guidelines
Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythropoeitin for Reducing Allogeneic Blood Transfusions in Colorectal Cancer Surgery." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453077/all/Erythropoeitin_for_reducing_allogeneic_blood_transfusions_in_colorectal_cancer_surgery.
Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453077/all/Erythropoeitin_for_reducing_allogeneic_blood_transfusions_in_colorectal_cancer_surgery. Accessed March 21, 2025.
Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453077/all/Erythropoeitin_for_reducing_allogeneic_blood_transfusions_in_colorectal_cancer_surgery
Erythropoeitin for Reducing Allogeneic Blood Transfusions in Colorectal Cancer Surgery [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453077/all/Erythropoeitin_for_reducing_allogeneic_blood_transfusions_in_colorectal_cancer_surgery.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery
ID - 453077
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453077/all/Erythropoeitin_for_reducing_allogeneic_blood_transfusions_in_colorectal_cancer_surgery
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
